The Workforce Needs of New Jersey's Pharmaceutical and Medical Technology Industry by unknown
The Workforce Needs of New Jersey’s  
Pharmaceutical and Medical Technology Industry
Prepared for 
HealthCare Institute of New Jersey and Member Companies
Prepared by 
John J. Heldrich Center for Workforce Development 
Edward J. Bloustein School of Planning and Public Policy 
Rutgers, The State University of New Jersey
May 2007

The Workforce Needs of New Jersey’s  
Pharmaceutical and Medical Technology Industry
HealthCare Institute of New Jersey 
95 Corporate Drive
MS 300
Bridgewater, NJ 08807
908.212.0333
www.hinj.org
John J. Heldrich Center for Workforce Development
Edward J. Bloustein School of Planning and Public Policy
Rutgers, The State University of New Jersey
30 Livingston Avenue
New Brunswick, NJ 08901
732.932.4100
www.heldrich.rutgers.edu
May 2007

About the Report
This report is based on an online survey 
conducted in spring 2006 of the current 
and future workforce needs of compa-
nies that are members of the HealthCare 
Institute of New Jersey (HINJ). More than 
two-thirds of HINJ member companies 
(15 of 22) responded to the survey. These 
companies represent 38,000 of the 60,000 
jobs at HINJ member companies. 
The survey requested information on 
employment by functional area, oc-
cupational title, educational level, and 
degree. Data were collected on num-
ber of employees, job openings, recent 
hires, and employment projections. In 
addition, HINJ member companies were 
also asked to assess the difficulty of hir-
ing specific occupations and degrees, 
using a low-medium-high scale. Data on 
graduates of New Jersey degree pro-
grams from the New Jersey Commission 
on Higher Education were assembled to 
provide a basis of comparison for work-
force supply. Finally, structured interviews 
were conducted with human resources 
managers at HINJ member companies to 
profile the skill and educational require-
ments of high-demand occupations.
This effort was guided by the HINJ Hu-
man Resources Committee. This com-
mittee, led by co-chairs Lisa Peterson, 
Vice President, Human Resources, Stryker 
Orthopedics, and Michael Kahrer, Vice 
President, Human Resources and Business 
Services, Organon, provided essential 
guidance throughout the project. Bill 
Healey, Executive Vice President, HINJ, 
also provided valuable input and guid-
ance.
This initiative was funded by the follow-
ing participating companies: ALTANA/Ny-
comed, Bristol-Myers Squibb, GE Health-
care, Hoffman-La Roche, Lundbeck Re-
search, Novartis, Novo Nordisk, Organon, 
Pfizer, sanofi-aventis, Schering-Plough, 
and Stryker Orthopedics.
High-Demand 
Occupations in New 
Jersey’s Pharmaceutical 
and Medical Technology 
Industry
 
Product Manager/ 
Marketing Manager 
 
Clinical Scientist 
 
Regulatory Affairs Manager 
 
Medical Doctor 
 
Biostatistician 
 
Engineer
1 Deloitte & Touche LLP, Challenges and Opportunities: New Jersey and the Pharmaceutical and Medical Technology Industry, 2006 annual economic report for the 
HealthCare Institute of New Jersey.
Executiv  Summary
The pharmaceutical and medical tech-
nology industry is, and will continue to 
be, an important part of the New Jersey 
economy. The industry employs 60,000 
people in New Jersey and has an esti-
mated impact of almost $27 billion on the 
state’s economy.1 New Jersey’s educat-
ed, skilled workforce is a primary reason 
for the industry’s success in the state. To 
help further enhance the industry’s suc-
cess, the state, led by Governor Corzine’s 
Office of Economic Growth and in  
partnership with state colleges and  
universities, is taking positive steps to help 
build a world-class workforce for New 
Jersey’s pharmaceutical and medical 
technology companies.
This report, based on an online survey 
conducted in spring 2006 of pharmaceu-
tical and medical technology companies 
in New Jersey, identifies the current and 
future workforce needs of the industry. 
The State of New Jersey and its educa-
tional institutions can use information 
from this report to develop partnerships 
and address industry needs. 
Findings
n  Pharmaceutical and medical  
 technology companies in New Jersey 
project modest growth across all  
 functional areas during the next four  
 years.
n M re than half of all jobs in th  industry 
are in corpor te administration (32%), 
sales (10%), and marketing (10%). More 
than one-quarter of jobs in the industry 
in the state are in basic research (17%) 
and clinical development (10%). 
n Companies project high levels of 
growth through 2010 for some occupa-
tions includi  linical scientists, public 
relations managers, regulatory aff irs 
managers, lawyers, and product  
managers/marketing managers.
n	New Jersey higher educational institu-
tions produce a relatively low number 
of students with several specific  
degrees in demand by the industry. 
These degrees include bachelor’s  
degrees in biochemistry, chemistry,  
animal science, and marketing, as  
well as master’s degrees and doctoral  
degrees in a variety of scientific  
and business areas.
n Companies report particular difficulty 
in hiring individuals for the following five 
occupations: product manager/ 
marketing manager, clinical scientist, 
regulatory affairs manager, medical 
doctor, and biostatistician. Medical 
technology companies, in particular,  
report a high level of difficulty hiring 
engineers. 
Introduction
The pharmaceutical and medical tech-
nology industry is a significant part of the 
state’s economy, providing jobs to 60,000 
people and having an economic impact 
of $27 billion.2
This report, based on a survey of com-
panies that are members of the Health-
Care Institute of New Jersey, describes 
employment in the industry by functional 
area, education level and degree, and 
occupation. The report also profiles six 
occupations for which companies report 
particular difficulty in hiring individuals.
Employment by 
Functional Area
The pharmaceutical and medical tech-
nology industry in New Jersey includes a 
broad range of operations, from admin-
istration to research to manufacturing. 
More than half of industry employment 
is in corporate administration, sales, and 
marketing. (See Figure 1.) Corporate ad-
ministration makes up almost one-third of 
all jobs in the industry, the single largest 
functional area in the state. Common 
jobs in this area include financial man-
agers, human resources managers, and 
information systems managers. An addi-
tional 10% of jobs are in sales and 10% in 
marketing. Common jobs in these areas 
include sales managers and product 
manager/marketing managers.
New Jersey is a significant center of re-
search and development for the industry. 
Seventeen percent of jobs in the industry 
in the state are in basic research, and 
10% of jobs are in clinical development. 
Common occupations in research and 
development include clinical scientists, 
medical doctors, and biologists.
Finally, the state is home to facilities 
that produce and manufacture phar-
maceuticals and medical products and 
devices. Fifteen percent of the jobs in the 
industry in New Jersey are in technical 
operations/manufacturing and an ad-
ditional 6% are in quality management. 
Common occupations in these areas 
include mechanical engineers, manufac-
2. Ibid.
Figure 1. Distribution of Pharmaceutical and Medical Technology Employment in 
New Jersey by Functional Area, 2006
turing engineers, quality assurance en-
gineers, manufacturing managers, and 
quality control managers.
The distribution of employment in the 
state by functional area is not expected 
to change during the next four years. 
However, companies report that they 
have the most difficulty in hiring employ-
ees for positions in marketing, basic re-
search, and clinical development. (See 
Table 1.)
Marketing
Companies report that marketing posi-
tions represent a disproportionate share 
of total job openings. While 10% of all cur-
Table 1. Distribution of Employment and Job Openings by 
Functional Area, 2006
Functional Area
Distribution 
of Current 
Workforce
Distribution  
of Open  
Positions
High Level 
of Hiring 
Difficulty
Corporate 
Administration
32% 28%
Sales 10% 9%
Marketing 10% 14% P
Basic Research 17% 18% P
Clinical Development 10% 17% P
Technical 
Operations/
Manufacturing
15% 11%
Quality Management 6% 3%
All Functional Areas 100% 100%
rent jobs are in marketing, 14% of current 
openings are in this area. Half of open 
marketing positions are new positions 
(growth) and half of the open positions 
are filling jobs held by employees who 
have left the company (replacement). By 
comparison, more than one-third (36%) of 
open positions in all functional areas are 
a result of growth. Finally, most compa-
nies responding to the survey report that 
they have difficulty in hiring employees in 
this area. (See Table 2.)
Basic Research
While companies do not have a dis-
proportionate number of openings in the 
area of basic research, most companies 
responding to the survey report that they 
have difficulty in hiring workers in this 
area. 
Clinical Development
Companies also report a high level of 
difficulty in hiring employees in clinical 
development. This area also has a dispro-
portionate share of open positions in the 
industry. Seventeen percent of open po-
sitions in the industry are in clinical devel-
opment, while only 10% of the industry’s 
jobs are in this area. Most of these open-
ings (71%) are due to replacement. 
Table 2. Cause of Job Openings by Functional Area, 2006
Functional Area
Percent of 
Positions Open 
Due to Growth
Percent of 
Positions 
Open Due to 
Replacement
High Level 
of Hiring  
Difficulty
Corporate 
Administration
31% 69%
Sales 37% 63%
Marketing 50% 50% P
Basic Research 37% 63% P
Clinical Development 29% 71% P
Technical Operations/
Manufacturing
38% 62%
Quality Management 41% 59%
All Functional Areas 36% 64%
Employment by 
Education Level
While the pharmaceutical and medical 
technology industry employs a significant 
number of highly educated individuals, 
the industry also employs individuals with 
a wide variety of educational experi-
ence. Nearly 70% of employees have 
earned a bachelor’s degree or higher. 
However, more than one-quarter of em-
ployees have earned only a high school 
diploma. (See Figure 2.)
The most common degree held by 
employees is a bachelor’s degree (46%). 
An additional 16% of employees hold a 
master’s degree as their highest degree 
attained. Finally, 7% of employees have 
earned a doctoral degree (Ph.D. or 
M.D.). 
Associate’s Degrees
The only common associate’s degree 
held by employees in the industry is one 
in business administration. Companies 
report moderate numbers of employees 
with an associate’s degree in business 
administration, but do not report any 
difficulty in hiring individuals with such a 
degree.
Bachelor’s Degrees 
The single most common degree held 
by employees in the industry is a bach-
elor’s degree in business administration. 
(See Table 3.) In fact, companies have 
Figure 2. Distribution of the Pharmaceutical and Medical Technology Employment in  
New Jersey by Highest Degree Attained, 2006    
nearly three times as many employees 
with this degree than the second most 
common degree, a master’s degree in 
the same discipline.
In addition, companies report that a 
significant number of employees possess 
bachelor’s degrees in finance, account-
ing, and computer information sciences. 
Companies report that they employ 
smaller numbers of individuals with bach-
elor’s degrees in other science fields. 
Recent hiring efforts by companies 
have disproportionately focused on indi-
viduals with bachelor’s degrees in busi-
ness administration, accounting, comput-
er information sciences, and biological 
sciences. 
Companies do not report any difficulty 
in hiring individuals with only a bachelor’s 
degree. However, New Jersey public 
higher educational institutions produce 
a relative small number of individuals 
with some specific degrees. The ratio of 
recent hires in the industry to recent New 
Jersey graduates is particularly low for 
bachelor’s degrees in marketing, animal 
science, biochemistry, and chemistry.  
Table 3. Employment Levels by Highest Degree Attained, Bachelor’s and Associate’s Degrees, 2006
Occupation Overall Employment*
High Proportion of Degreed 
Employees Who are  
Recently Hired**
Low Ratio of Recent  
Hires to Recent  
New Jersey Graduates*
A.A. - Business Administration Medium
B.A. - Business Administration Large P
B.A. - Finance Large
B.A. - Accounting Large P
B.A. - Marketing Small P
B.A. - Communications Small
B.A. - Electrical Engineering Small
B.A. - Mechanical Engineering Medium
B.A. - Chemical Engineering Small
B.A. - Computer Information Sciences Large P
B.A. - Animal Sciences Small P
B.A. - Biological Sciences Medium P
B.A. - Biochemistry Small P
B.A. - Chemistry Medium P
B.A. - Mathematics/Applied Mathematics Small
B.A. - Microbiology Small
B.A. - Nursing Small
B.A. - Pharmaceutical Sciences Small
* Employment is indicated as large, medium, or small by evaluating the total employment count, as well as the ranking of the occupation within a 
company. 
** Statistic is calculated using (Number of Employees Hired in Past Year)/(Current Employment). The result is ranked within companies, and the 
lowest average rankings indicate high levels. 
*** Source: New Jersey Commission on Higher Education, 2002-2005 data on degrees conferred (SURE system). 
New Jersey graduates with each degree are identified using Cipcodes. (Recent Graduates)/(Recent Hires) is calculated to indicate relatively low supply. 
Master’s Degrees
Companies report high numbers of 
employees with a master’s degree in 
business administration (M.B.A.). Com-
panies also have moderate numbers of 
employees with master’s degrees in fi-
nance, marketing, computer information 
sciences, and biological sciences. (See 
Table 4.)
Companies also report that recent 
hiring efforts have disproportionately in-
cluded individuals with a master’s degree 
in business administration, marketing, 
computer information sciences, and bio-
logical sciences.
New Jersey higher educational institu-
tions produce relatively low numbers of 
individuals with master’s degrees that 
are in demand by the industry. Of the 
eight master’s degrees commonly hired 
by companies, five have a low ratio of 
recent New Jersey graduates to recent 
hires by the industry: finance, marketing, 
chemical engineering, computer infor-
mation sciences, and chemistry.  
New Jersey educational institutions 
graduate a relatively high number of stu-
dents with M.B.A.s. However, pharmaceu-
tical and medical technology companies 
report a high level of difficulty in finding 
employees with M.B.A.s. Companies also 
report a high level of difficulty in hiring in-
dividuals with a master’s degree in com-
puter information sciences.
 
Doctoral Degrees
Employees with doctoral degrees are 
largely concentrated in basic research 
and clinical development. In fact, nearly 
9 in 10 employees with doctoral degrees 
hold a degree in a math or science disci-
pline. The single most common doctoral 
degree held by employees is an M.D.
Companies report that they have a 
high level of difficulty in hiring individuals 
with all types of doctoral degrees with 
one exception: companies do not report 
difficulty in hiring individuals with a Ph.D. 
in biochemistry. In addition, New Jersey’s 
higher educational institutions produce a 
relatively small number of individuals with 
Ph.D.s in biological sciences, chemistry, 
and pharmaceutical sciences.  
Table 4. Employment Levels by Highest Degree Attained, Master’s and Doctoral Degrees, 2006
Occupation
Overall 
Employment*
High Proportion of Degreed  
Employees Who are  
Recently Hired**
High Level of  
Hiring Difficulty
Low Ratio of Recent  
New Jersey Graduates to  
Recent Hires***
M.A. - Business Administration 
(M.B.A.)
Large P P
M.A. - Finance Medium P
M.A. - Marketing Medium P P
M.A. - Chemical Engineering Small P
M.A. - Computer Information Sciences Medium P P P
M.A. - Biological Sciences Medium P
M.A. - Chemistry Small P
M.A. - Medicine Small
Ph.D. - Biological Sciences Small P P
Ph.D. - Biochemistry Small
Ph.D. - Chemistry Small P P
Ph.D. - Pharmaceutical Sciences Small P P
M.D. Medium P P
* Employment is indicated as large, medium, or small by evaluating the total employment count, as well as the ranking of the occupation within a company. 
** Statistic is calculated using (Number of Employees Hired in Past Year)/(Current Employment). The result is ranked within companies, and the lowest average rankings indicate high levels. 
*** Source: New Jersey Commission on Higher Education, 2002-2005 data on degrees conferred (SURE system). 
New Jersey graduates with each degree are identified using Cipcodes. (Recent Graduates)/(Recent Hires) is calculated to indicate relatively low supply. 
Employment by 
Occupation
Administration, Sales, and 
Marketing Occupations
Corporate headquarters functions 
represent the largest share of employees 
in the industry in the state. Five specific 
occupations in this functional area have 
significant levels of employment: financial 
manager, human resources manager, 
information systems manager, sales man-
ager, and product manager/marketing 
manager. (See Table 5.) In fact, the single 
largest occupation in the entire industry 
in the state is product manager. Product 
managers also account for the largest 
number of current openings in  
the industry. 
Two occupations with moderate levels 
of current employment have a high level 
of job openings. General and operations 
managers and regulatory affairs manag-
ers have a high ratio of current openings 
to current employment. Companies proj-
ect employment growth between 2006 
and 2010 in four occupations: regulatory 
affairs managers, lawyers, product man-
agers, and public relations managers.
Companies also report that they have 
a high level of difficulty in hiring regula-
tory affairs managers and product man-
agers. Both of these occupations have 
relatively high levels of job openings and 
are expected to grow during the next 
four years.
Table 5. Employment by Occupation: Administration, Sales, and Marketing, 2006 
Occupation
Current 
Employment*
High Level  
of Job  
Openings**
High Level  
of Hiring 
Difficulty
 High Employment 
Growth  
through 2010***
General and Operations 
Manager
Medium P
Governmental Affairs 
Manager
Small
Financial Manager Large P
Human Resources Manager Large
Public Relations Manager Small P
Regulatory Affairs Manager Medium P P P
Lawyer Medium P
Information Systems Manager Large P
Sales Manager Large P
Product Manager/Marketing 
Manager
Large P P P
Purchasing Agent/Buyer Medium
* Employment is indicated as large, medium, or small by evaluating the total employment count, as well as the ranking of the 
occupation within a company. 
** Statistic is calculated using (Number of Job Openings)/(Current Employment). The result is ranked within companies, and 
the lowest average rankings indicate high levels and well-dispersed job openings. 
*** Statistic is calculated using (Projected Employment)/(Current Employment). The result is ranked within companies, and 
the lowest average rankings indicate high levels of growth that is well dispersed. 
Table 6. Employment by Occupation: Research/Clinical Development, 2006 
Occupation
Current 
Employment*
High Level 
of Job 
Openings**
High Level 
of Hiring 
Difficulty
High Employment 
Growth  
through 2010***
Biochemist Medium
Biologist Large
Biophysicist Small
Biostatistician Medium P
Chemist Medium
Clinical Scientist Medium P P
Medical Doctor Medium P P
Microbiologist Small
Nurse Small
Pharmacist Medium
Research Associate Large P
Veterinarian Small
* Employment is indicated as large, medium, or small by evaluating the total employment count, as well as the ranking of the 
occupation within a company.     
** Statistic is calculated using (Number of Job Openings)/(Current Employment). The result is ranked within companies, and 
the lowest average rankings indicate high levels and well-dispersed job openings. 
Research/Clinical Development 
Occupations
Four research and clinical develop-
ment positions have high levels of em-
ployment: biologists, clinical scientists, 
medical doctors, and research associ-
ates. (See Table 6.) Of these four occupa-
tions, only one, biologists, does not have 
a high level of current job openings. All 
three other occupations exhibit a high 
ratio of current openings to current em-
ployment.
While companies expect that overall 
employment in research and clinical de-
velopment will grow modestly during the 
next four years, companies expect high 
growth in the number of clinical scientists. 
Companies report that they have a 
high level of difficulty in hiring two re-
search and clinical development oc-
cupations: biostatisticians and medical 
doctors. 
Technical Operations/
Manufacturing and Quality 
Management
Six occupations in the area of technical 
operations/manufacturing and quality 
management have moderate levels of 
employment, including mechanical en-
gineers, manufacturing engineers, and 
quality control managers. Medical tech-
nology companies report a high level 
of difficulty in hiring materials research, 
product design and development,  
and quality assurance engineers. (See 
Table 7.)
*** Statistic is calculated using (Projected Employment)/(Current Employment). The result is ranked within companies, and 
the lowest average rankings indicate high levels of growth that is well dispersed. 
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Table 7. Employment by Occupation: Technical Operations/Manufacturing and Quality 
Management, 2006 
Occupation Current Employment* High Hiring Difficulty
Chemical Engineer Small
Electrical Engineer Small
Mechanical Engineer Medium
Manufacturing Engineer Medium
Materials Research Engineer Small P 
Packaging Engineer Small
Product Design/Development Engineer Small P 
Production Planner Small
Quality Assurance Engineer Medium P  
Test Engineer Small
Animal Handler/Technician Medium
Biological Technician Small
Chemical Technician Small
Manufacturing Manager Medium
Quality Control Manager Medium
Chemical Engineer Small
* Employment is indicated as large, medium, or small by evaluating the total employment count, as well as the ranking of the 
occupation within a company. 
** Medical technology companies
 **
 **
 **
High-Demand 
Occupations
Six occupations in the pharmaceutical 
and medical technology industry can be 
classified as high-demand occupations, 
based on the following factors (see  
Table 8):
n	Reported difficulty in hiring new em-
ployees,
n	A large number of employees, and
n	Expected growth in the occupation.
In addition, some of these occupations 
require educational degrees that have a 
low supply of recent graduates in  
New Jersey.
Product Manager/Marketing 
Manager
According to companies responding to 
the survey, product manager is the single 
largest occupation in the industry in the 
state. 
Product managers play a crucial role 
in the pharmaceutical and medical 
technology industry. They are the main 
individuals responsible for managing all 
aspects of specific products or portfo-
lios of products. They manage business 
development and marketing, and more 
specifically they are responsible for mar-
ket and therapy assessments, vendor re-
lationships, and developing and coordi-
nating marketing activities to support the 
commercialization of products. They work 
closely with research and clinical devel-
opment staff and with individuals in a 

Table 8. Summary Results: High-Demand Occupations
Occupation Occupational Demand Characteristics
Product Manager/
Marketing Manager
Very high-volume position with many openings and significant growth 
projections. Rated to have high hiring difficulty.
Clinical  
Scientist
High-volume position with considerable job openings and substantial growth 
projections. Rated with medium to high hiring difficulty.
Regulatory Affairs  
Manager
Medium-volume position with extensive penetration and high-growth 
projections. Rated to have high hiring difficulty.
Medical  
Doctor
Medium high-volume position with many open positions. Very high hiring 
difficulty indicated.
Biostatistician Medium-volume position with high indicated hiring difficulty.
Engineer
Medium-volume position at some companies with high hiring difficulty at 
medical technology companies.
variety of corporate administration func-
tions. Successful product managers have 
strong teamwork and communication 
skills, knowledge of scientific disciplines, 
and may need to possess substantial 
knowledge of a therapeutic area.
Companies report that there are a 
significant number of job openings in this 
occupation. Companies also project that 
the number of product managers in the 
state will grow during the next four years. 
Most importantly, companies report that 
they have a high level of difficulty in hir-
ing individuals in this occupation. 
Product managers are normally re-
quired to have an M.B.A. and between 
three to five years of relevant experience. 
Some companies, however, report that 
they are willing to train recent M.B.A. 
graduates if they have some prior, rel-
evant experience. Many openings are 
filled by the promotion of more junior staff 
members. When companies hire individu-
als from outside of the company, they 
tend to prefer applicants who have ex-
perience in the pharmaceutical or medi-
cal devices industry. 
New Jersey higher educational institu-
tions produce a relatively large number 
of graduates with M.B.A.s. However, com-
panies note that many of these gradu-
ates have not focused their education 
on marketing in the pharmaceutical and 
medical technology industry.
Clinical Scientist
Companies in the pharmaceutical 
and medical technology industry in New 
Jersey employ considerable numbers of 
clinical scientists. Companies report a 
moderate to high level of difficulty in hir-
ing individuals for this position. In addition, 
there are a relatively large number of job 
openings for this position, and compa-
nies project that the number of clinical 
scientists will increase during the next four 
years.
Clinical scientists are responsible for 
managing clinical trials and related re-
search. They are responsible for the plan-
ning, implementation, and monitoring of 
clinical studies in all phases of drug and 
medical device development. In ad-
dition to being responsible for all data 
collection activities, clinical scientists 
also interpret results. Consequently, clini-
cal scientists must have strong project 
management, business knowledge, and 
scientific skills. Clinical scientists must be 
able to effectively manage timelines, 
budgets, and various stakeholders. 
Clinical scientists are required to have 
a PharmD or a master’s degree in a rel-
evant science discipline. Companies will 
often hire clinical scientists from clinical 
research organizations, companies that 
conduct clinical trials on contract for 
pharmaceutical companies.

Regulatory Affairs Manager
Regulatory affairs managers are re-
sponsible for ensuring that new phar-
maceutical and medical technology 
products are approved by the Food and 
Drug Administration and other appropri-
ate regulatory agencies in the United 
States and other countries. They work 
closely with research and development 
and marketing teams to compile regula-
tory dossiers. Regulatory affairs managers 
also work in a variety of functional areas 
including labeling, drug development, 
manufacturing, and advertising and pro-
motion. 
While there are only a moderate num-
ber of regulatory affairs managers in the 
industry, every company responding to 
the survey employs such managers. In 
addition, regulatory affairs managers 
have a relatively high level of job open-
ings. Companies also expect significant 
growth in the number of regulatory affairs 
managers during the next four years.
The education requirements for this po-
sition vary widely depending on the ex-
pected level of responsibility. Education 
requirements can range from a bache-
lor’s degree in a science discipline for en-
try-level managers to a Ph.D. for manag-
ers with a higher level of responsibility. In 
addition to an appropriate degree, regu-
latory affairs managers generally need at 
least three to seven years of experience 
in regulatory issues. 
Regulatory affairs managers must have 
both scientific expertise and business 
skills. Successful managers need strong 
technical skills, interpersonal/communi-
cation skills, a strong desire to learn, and 
the ability to adapt to change. At large 
companies, regulatory affairs managers 
specialize in specific substantive areas. At 
small companies, managers usually have 
responsibility for a wider variety of areas 
and must have broad, cross-functional 
experience.
Companies responding to the survey 
report a high level of difficulty in hiring 
regulatory affairs managers. In addition, 
New Jersey educational institutions pro-
duce a relatively small number of indi-
viduals with appropriate degrees for this 
position, including a bachelor’s degree 
in biochemistry and chemistry, master’s 
degrees in chemistry, and doctoral de-
grees in chemistry and pharmaceutical 
science. 
Medical Doctor
Medical doctors play a variety of roles 
within the pharmaceutical and medical 
technology industry. Medical doctors typ-
ically work on clinical trials and interface 
with the Food and Drug Administration. 
Medical doctors also work in medical 
affairs positions where they provide guid-
ance to product managers regarding 
drug labeling and other matters. Medical 
doctors can also act as liaisons, provid-
ing training to practicing medical doctors 
who are interested in, or have questions 
about, the company’s products. Finally, 
medical doctors can also play a role in 
sales and marketing functions by inter-
facing with practicing doctors who may 
use or prescribe the company’s products. 
Companies employ a moderate num-
ber of medical doctors and report a very 
high degree of difficulty in hiring them. In 
addition, there are a relatively large num-
ber of job openings for medical doctors 
in the industry. 
The role of medical doctors in the 
industry is quite different from private 
practice. As a result, companies typi-
cally prefer to hire medical doctors with 
experience in the industry. Experience 
with clinical trials in a hospital setting may 
substitute for formal industry experience, 
in some cases. Hiring medical doctors 
directly from private practice can be a 
difficult venture. Companies report that 
some doctors coming from that setting 
have unrealistic expectations of industry 
employment and find the transition more 
difficult than anticipated.
Biostatistician
While pharmaceutical and medical 
technology companies employ a moder-
ate number of biostatisticians, companies 
report a high level of difficulty in hiring 
individuals for these positions. Biostatisti-
cians work closely with clinical research 
scientists to perform statistical analyses 
in support of clinical trials. They manage 
biometrics work including statistical anal-
yses, programming and data manage-
ment, and quality control of these activi-
ties. In addition, biostatisticians serve on 
clinical research project teams. They  
also provide input and support to  
regulatory affairs managers on regulatory 
submissions.  

Biostatisticians are normally required 
to have a doctoral degree in statistics or 
biostatistics. In some cases, companies 
will hire biostatisticians with a master’s 
degree in statistics or another science dis-
cipline. Companies prefer to hire individu-
als with three to five years of experience 
but will hire individuals with no experi-
ence in some instances. Companies in-
terviewed report that biostatisticians must 
have strong teamwork skills, possess an 
entrepreneurial spirit, and be innovative 
in order to be successful in the industry.
Engineer
Engineers, in a variety of disciplines, are 
essential employees in medical technol-
ogy companies and in some pharma-
ceutical companies. Companies report 
employing a moderate number of me-
chanical, manufacturing, and quality as-
surance engineers. 
Medical technology companies, in 
particular, report a high level of difficulty 
in hiring engineers. These companies 
— which conduct research, and design 
and manufacture medical products, 
such as orthopedic implant devices and 
instrumentation and medical diagnostic 
devices — report a high level of difficulty 
in hiring materials research, product de-
sign and development, and quality assur-
ance engineers. 
Engineers are typically required to have 
a bachelor’s of science degree or mas-
ter’s of science degree in an engineering 
discipline, such as mechanical, indus-
trial, electrical, or chemical engineering. 
They are also typically required to have 
experienced applications labs in various 
specialty areas such as biomechanics or 
electronics.


Workforce Partnerships of New Jersey’s Pharmaceutical and  
Medical Technology Industry
The following section is a compilation 
of the workforce and training education 
partnerships currently undertaken by the 
member companies of the HealthCare 
Institute of New Jersey (HINJ). It is not 
part of the Heldrich Center’s research for 
HINJ, but is provided by each company for 
informational purposes.
BD
BD, a leading global medical technology 
company that manufactures and sells 
medical devices, instrument systems, 
and reagents, is dedicated to improving 
people’s health throughout the world. 
BD is focused on improving drug therapy, 
enhancing the quality and speed of 
diagnosing infectious diseases, and 
advancing research and discovery of 
new drugs and vaccines. The company’s 
capabilities are instrumental in combating 
many of the world’s most pressing diseases. 
Founded in 1897 and headquartered in 
Franklin Lakes, NJ, the company employs 
more than 25,000 people in approximately 
50 countries throughout the world. The 
company serves health care institutions, life 
science researchers, clinical laboratories, 
industry, and the general public.
The BD Matching Gift Program matches 
associates’ gifts made to accredited, 
nonpublic primary and secondary schools, 
and special education schools up to and 
including an aggregate of $1,000. Higher 
education is matched dollar for dollar up to 
$10,000 per calendar year per associate. In 
FY2006, BD matched $281,307 to education, 
$58,687 to schools in New Jersey, $44,462 
to higher education, and $14,225 to K-12 
education.
New Jersey SEEDS 
BD funds support a statewide program 
that provides educational opportunities to 
children of high academic potential whose 
families are financially limited. Through 
the SEEDS program, scholars of diverse 
economic and racial backgrounds are 
brought together and given the academic 
preparation and financial assistance they 
need to gain entrance to an independent 
school and achieve success in their new 
environments.
Ramapo College Foundation
BD supports the BD Scholars Program to 
benefit two entering freshman per year 
at Ramapo College of New Jersey. The 
primary goal of the BD Scholars Program is 
to give minority students from underserved 
communities an opportunity to achieve 
a college degree. Candidates for the 
scholarship will be interested in health-
related areas such as nursing.
The Saint Barnabas Health Care System 
Foundation
BD supports a two-part relationship as 
follows: (1) To enhance patient safety 
throughout the hospital by helping the 
hospital to implement projects such 
as a patient safety log, computerized 
physician order entry, and medication 
reconciliation. This protocol will then be 
used and replicated throughout to other 
units and systems. (2) To support the Renal 
Transplant Classroom partnership. BD is 
part of a collaboration between the Saint 
Barnabas Health Care System Foundation, 
Liberty Science Center, and New Jersey’s 
Organ and Tissue Sharing Network. Through 
this educational collaboration, BD’s 
support is used to advance the way New 
Jersey high school students learn about 
health science, stimulate greater interest 
in becoming health professionals, promote 
the vital importance of organ donation, 
and encourage healthy living choices. 
The two-way interactive videoconference 
surgical experience is broadcast live from 
the operating rooms at Saint Barnabas 
Medical Center directly to New Jersey 
high school students in the Liberty Science 
Center amphitheater.
William Paterson University
The BD/Russ Berrie Institute Sales scholarship 
at William Paterson was created to provide 
a stream of qualified diverse globally 
focused sales professionals. The scholarships 
help to provide critical financial assistance 
and encouragement needed for students 
to continue their education. 
Fairleigh Dickinson University
Through this grant, BD supports the 
expansion of the Henry P. Becton School 
of Nursing and Allied Health to include a 
doctoral program to prepare nurses for 
leadership in the clinical and education 
areas.
Independent College Fund of New Jersey
The BD Higher Education and Leadership 
Training for Healthcare (HEALTH) Program 
is designed to facilitate the creation of 
a talented new generation of health 
care providers who will make significant 
contributions in helping people around the 
globe lead healthier lives. The goal of the 
BD HEALTH Program is to encourage student 
achievement and foster faculty leadership 
and commitment in the area of health 
care, especially as it relates to the fields of 
applied science, health care management, 
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public health policy, and nursing. Ultimately, 
the program helps address emerging and 
long-term health care needs by preparing 
undergraduate students in the breadth 
and depth of knowledge required to work 
in today’s global health care arena. BD 
also annually supports general operating 
scholarship donations to member schools.
Hope Chest Scholarship
The Hope Chest Scholarship Foundation 
helps minority students in New Jersey enroll 
in and graduate from college by providing 
financial assistance.
New Jersey Institute of Technology (NJIT)
Proceeds from a gala event are used to 
provide scholarship assistance to deserving 
students in NJIT’s Albert Dorman Honors 
College.
Bayer HealthCare 
Pharmaceuticals
Bayer HealthCare Pharmaceuticals Inc., 
headquartered in Wayne, NJ, is the 
U.S.-based pharmaceuticals unit of 
Bayer HealthCare. Bayer HealthCare’s 
pharmaceutical business is dedicated to 
developing, manufacturing, and marketing 
products that help improve human health, 
and globally ranks among the top 10 
specialty pharmaceutical companies. 
The global pharmaceutical business 
employs more than 40,000 people, with 
approximately 5,500 employees in the 
United States. 
Bayer’s combined pharmaceutical portfolio 
includes product offerings in, and research 
groups devoted to, Diagnostic Imaging, 
Hematology/Cardiology, Oncology, 
Specialized Therapeutics, and Women’s 
Health Care. Leading products in the United 
States include:
n	A	first-in-class	oral	oncology	treatment	for	
adults with kidney cancer.
n	The	first	disease-modifying	therapy	for	use	
among patients with relapsing remitting 
multiple sclerosis.
n	The	first	I.V.	contrast	agent	for	use	in	mag-
netic resonance imaging.
n	A	recombinant	human	factor	VIII	treat-
ment recommended for people living 
with hemophilia A.
n A unique intrauterine contraceptive sys-
tem, which is 99.9 percent effective for up 
to	five	years.
n	The	first	oral	contraceptive	(OC)	to	con-
tain the unique progestin drospirenone, 
introduced in 2001.
n	The	first	and	only	OC	ever	approved	by	
the FDA for three distinct indications: as 
an OC, as well as a treatment for acne 
and/or the emotional and physical  
symptoms of premenstrual dysphoric  
disorder in women choosing an OC  
for contraception.
Informing College Students About Career 
Opportunities
n Precept current sixth-year Rutgers  
University, Ernest Mario School of  
Pharmacy students during five-week  
rotational assignments
l	Students gain practical experience in  
Medical Information Services.
l	Students meet with members of various  
departments in the company to discuss 
the career opportunities available to  
PharmD’s.
Internship Programs
n Rutgers PharmD Fellowship Program. In 
partnership with the Ernest Mario School 
of Pharmacy, Rutgers University, offers a 
two-year Pharmaceutical Industry Fellow-
ship Program.
n Health Economics Internship
l	Health Economics internship for stu-
dents of Pharmacy or Public Health to 
analyze the implications of therapies in 
the marketplace, as well as the impact 
of health care policies on the access 
to health care. Students have the op-
portunity to become fellows receiving 
educational non-restrictive grants.  
l	Typically summer internship full-time for 
a duration of 12 weeks. 
n Organizational Psychology Internship
l	Internship provided for doctoral stu-
dents in Psychology at Rutgers Univer-
sity Graduate School of Applied and 
Professional Psychology.
l	16-40 hours per week, depending on 
student’s schedule, for 1-2 years.
l	Study and practice in all areas related 
to organizational psychology practice 
in industry: Attitude survey design, ad-
ministration, and follow-up; Human  
Resource systems design and integra-
tion; Change Management; Team  
development; and Research.
Curriculum Design
n Assisted Fairleigh Dickenson University in 
designing a graduate level Pharmaceuti-
cal Chemistry program.
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Bristol-Myers Squibb 
Bristol-Myers Squibb is one of the leading 
pharmaceutical and related health care 
companies in the world. The company’s 
mission is to extend and enhance human 
life by providing the highest quality 
pharmaceutical and related health care 
products. New Jersey is home to eight 
Bristol-Myers Squibb campuses and nearly 
8,000 employees.    
     
Centers for Science Teaching and 
Learning 
Bristol-Myers Squibb has a long history 
of supporting science education and 
developing programs to strengthen 
the teaching of science in schools. This 
commitment has led to the establishment of 
university teacher training centers designed 
to improve how science is taught at every 
level, from kindergarten through college. 
Two such centers have been developed 
in New Jersey, one at Montclair State 
University and the other at Rider University 
in Lawrenceville. These centers are focal 
points for regional activities in science 
education reform, administering needs 
analyses, coordination of services to 
educators, and evaluation of progress. A 
growing network of these centers will ensure 
broad dissemination of best practices for 
schools and students.
n Montclair State University: Established in 
2005 through a grant from Bristol-Myers 
Squibb, the Bristol-Myers Squibb Center 
for Science Teaching and Learning on 
the campus of Montclair State University 
is the hub of a Montclair State initia-
tive to improve teacher preparation in 
mathematics and science. The initiative, 
known as PRISM (Professional Resources in 
Science and Mathematics), emphasizes 
inquiry-based teaching strategies and in-
structional uses of technology to improve 
student outcomes. 
n Rider University: In 2002, Bristol-Myers 
Squibb funded the creation of the Bristol-
Myers Squibb Center for Science Teach-
ing and Learning at Rider University. This 
facility is the home of SELECT (Science 
Education and Literacy Center), a uni-
versity initiative dedicated to improv-
ing teaching and learning in science 
and mathematics from kindergarten 
through college. The ongoing Bristol-My-
ers Squibb/Rider University Grant Program 
for Enhancement of Science Teaching 
also supports initiatives that improve the 
teaching of science. 
Rutgers College of Nursing
Bristol-Myers Squibb has donated, over the 
period of three years, $150,000 toward the 
construction of a new building in downtown 
New Brunswick, NJ for the College of 
Nursing at Rutgers, The State University of 
New Jersey. Bristol-Myers Squibb’s donation 
will assist Rutgers with its initiative to provide 
a state-of-the-art facility for its nursing 
students studying at the New Brunswick/
Piscataway campus. Groundbreaking for 
the new College of Nursing building took 
place in late 2005.
Cardinal Health
Cardinal Health serves the health care 
industry with a broad portfolio of products 
and services that help customers reduce 
costs, improve safety and productivity, 
and deliver better care to patients. Its 
Pharmaceutical Technologies and Services 
business segment, headquartered in 
Somerset, NJ, is the leading provider of 
pharmaceutical development services, 
drug delivery technologies, manufacturing, 
packaging, and product commercialization 
services to the global pharmaceutical and 
biotechnology industry. Among its more 
than a thousand patents for drug delivery 
systems are Zydis®  fast-dissolve,	Vegicaps®  
Soft plant-derived softgel, Microsponge®  
time-release, and Del Pouch®  single-dose 
pouch/applicator technologies. 
Cardinal Health firmly believes in helping 
to advance New Jersey’s already strong 
culture of science and innovation by 
participating in industry associations, 
recruiting top talent from area universities, 
and contributing to the local community.  
 
n Cardinal Health recruits full-time employ-
ees for a variety of scientific and  
management positions from Rutgers Uni-
versity and the New Jersey Institute  
of Technology. 
n Cardinal Health recruits recent graduates 
from Rutgers University for its Manufactur-
ing Development Program, a rotational 
leadership development program de-
signed to give trainees exposure to  
the areas of quality, manufacturing,  
materials management, and project 
management. 
n Through a 12-week Summer Intern Pro-
gram, Cardinal Health offers students 
from Rutgers University an opportunity to 
gain valuable work experience at a U.S. 
manufacturing facility. 
n As a member of the New Jersey Technol-
ogy Council, Cardinal Health has offered 
educational opportunities for members 
affiliated with the life sciences.  
n Through its annual “Take Your Children 
to Work Day” event, Cardinal Health 
employees demonstrate to elementary 
school students the value of science in 
society and the importance of working in 
the health care industry. 
n Cardinal Health’s Somerset facility re-
ceived the Somerset County Economic 
Development Council Award (2005) from 
the Somerset County Business Partnership 
in recognition of its economic impact on 
Somerset County in terms of job creation 
and training, sales growth, profitability, 
and reinvestment.
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Celgene
Celgene Corporation and its employees 
are working relentlessly to provide solutions 
for unmet medical needs in cancer and 
debilitating	inflammatory	diseases.	Its	goal	
is to provide next-generation therapies that 
deliver quality outcomes for better health 
care. Celgene is dedicated to improving 
health care by delivering more disease-
altering therapies to patients in need. In 
fact, there are more than 200 ongoing 
clinical trials at major medical centers 
worldwide using innovative compounds 
from Celgene. These promising drugs 
include many high-potential compounds 
in our rich regulatory pipeline. These 
investigational compounds are being 
actively studied in clinical trials for patients 
with incurable hematological and solid 
tumor cancers, including multiple 
myeloma, myelodysplastic syndromes, 
chronic	lymphocytic	leukemia	(CLL),	non-
Hodgkins lymphoma, glioblastoma, ovarian, 
pancreatic, and prostate cancer. 
Celgene is committed to improving the 
lives of patients worldwide. By utilizing the 
latest advances in molecular and cellular 
research to develop novel therapies that 
target the mechanisms of disease at their 
source, Celgene is making potentially life-
saving treatments a reality for the millions of 
patients around the world fighting cancer 
and other debilitating diseases.
Given the rapid growth within the 
biotechnology and pharmaceutical 
sector, Celgene along with other large 
pharmaceutical and biotechnology 
companies compete for the same talent 
base in New Jersey. Having hired over 600 
employees in the past four years, it has 
become increasingly difficult to source 
existing high-caliber talent specifically in 
the scientific and clinical development 
functions and especially Clinical Scientists, 
Clinical Operations, Clinical Physicians, and 
Biostatisticians. The demand at this juncture 
clearly outweighs the supply. Celgene 
has begun to work with New Jersey higher 
education to assist not only with awareness 
but to begin to develop partnerships for 
cultivating future talent in these areas. 
It will be critical for New Jersey to focus 
both on increasing the enrollment of 
students in these degreed and advanced 
programs and to further develop within the 
curriculum, active practical learning that 
will facilitate graduates who have actual 
work experience correlating to the growing 
gap that exists for this base of talent in 
the state. Further, state assistance to such 
programs will keep jobs in the state as the 
talent will be available for corporations.
Celgene is committed to the continuous 
development of scientific literacy 
among students within the New Jersey 
college system. Its ongoing ability to 
attract, retain, and develop future 
talent directly correlates with its ability 
to form collaborative relationships with 
academicians at Rutgers University and 
the University of Medicine and Dentistry 
(UMDNJ) and other higher learning 
institutions within New Jersey. Although 
Celgene is relatively early on in this initiative, 
the company is proud of its achievements 
to date and looks forward to expanding its 
efforts in the near future.  
Some examples of its initial framework are: 
Celgene contributes to the RISE (Research 
in Science and Engineering) program, 
which is a jointly sponsored program by 
Rutgers and UMDNJ designed to promote 
and advance undergraduate diversity 
in science, math, and engineering. This 
summer program sponsors outstanding 
undergraduates to participate in cutting-
edge research in sciences, math, and 
engineering. In 2007, Celgene plans to 
sponsor and track the progress of one to 
two students until their graduation dates. 
Subsequently, Celgene will invite them to 
interview for positions within its scientific 
functions. To this point, in addition to New 
Jersey actively supporting the development 
of student capability within the science and 
clinical arena, there is a further dimension 
of diversity. With the growing Hispanic and 
African American population, RISE is a 
great example of a program designed to 
not only increase the availability of talent 
in this specific area but also build a pool of 
diverse talent.
Additionally, in 2006, Celgene initiated 
a paid internship program, CREW 
(Clinical Research Editors and Writers), in 
collaboration with Douglass College at 
Rutgers. The goal of the program was to 
introduce students to careers in science 
and medical writing. It was available 
to undergraduate students in biology 
and other science majors. The internship 
program assignment ran in summer 2006 
and students received course credits 
toward their degrees for the time they spent 
working within the medical writing function 
at Celgene.
Finally, Celgene has also provided 
sponsorship funding for fellowship programs 
at Rutgers to build talent. In 2007, Celgene 
will sponsor two fellowship programs at 
Rutgers. One program has been set up in 
memory of a former employee and will be 
in the general science area covering a 
diversity of scientific subjects. The second 
fellowship will be in drug discovery and will 
span a variety of scientific disciplines to 
ensure that the participant(s) are trained 
across the spectrum of scientific disciplines 
that comprise the drug discovery process. 
The students will complete their fellowship 
programs primarily at the college but will 
also have the opportunity to work within 
Celgene to gain firsthand experience of the 
drug discovery and development process.
Celgene is committed to bringing the 
important benefits of its innovative therapies 
to thousands of people around the world. 
The company is establishing broad patient 
support programs to help ensure that 
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patients will continue to have access to the 
clinical benefits that Celgene’s innovative 
therapies can provide, and is working hard 
to rapidly advance promising new drugs for 
cancer and inflammatory-based diseases 
so that even more patients in need can be 
helped. 
Celgene’s ability to continue its commit-
ment to patients and its future success 
requires planning to cultivate and access 
the skills, experience, and capability of 
talent it will need. The company fully 
supports the collaboration and partnership 
of HINJ as it seeks to collectively address this 
current and future challenge in New Jersey.
Chugai Pharma U.S.A., LLC
As a member of the Chugai-Roche 
Group,	Chugai	Pharma	USA	LLC	(CPUSA),	
founded in 1995 in San Diego, CA and 
currently based in Bedminster, NJ, is 
committed to the timely development 
and commercialization of safe and 
effective drugs for the North American 
marketplace. For more than 70 years, its 
parent company, Chugai Pharmaceutical 
Co. Ltd., has provided high-quality, safe, 
and effective drugs to the Japanese and 
global marketplace, a heritage that will 
be continued in North America by CPUSA. 
As a result of its alliance with F. Hoffmann-
La Roche Ltd. in 2002, CPUSA enjoys the 
resources of a large global conglomerate 
while preserving the focus and agility of 
a small local company. CPUSA maintains 
the same therapeutic focuses as its parent, 
currently working mainly in the areas of 
treatments for cardiovascular disease, 
cancer, metabolic disease, and diseases 
involving	inflammation.	It	is	a	company	of	
collaborative, committed, talented, and 
experienced people with an unwavering 
dedication to quality and the highest 
environmental and ethical standards. Its 
employees all take great pride in bringing 
new	medicines	to	market	for	the	benefit	of	
those in need.
CPUSA’s mission is to contribute local 
experience,	expertise,	and	flexibility	to	
Chugai’s global effort to rapidly develop 
and market high-quality, innovative 
therapies	for	the	benefit	of	human	health	
and the maximization of shareholder 
value, and to create additional value by 
emphasizing advancements in specialty 
indications for the North American market.
In support of educational excellence, 
Chugai Pharma supports the following 
universities and associations: 
n Chugai Award for Excellence in Men-
toring and Scholarship, presented to a 
member of the American Society for  
Investigative Pathology with a distin-
guished career that especially links excel-
lence in mentoring and education  
with outstanding research achievements 
in experimental and investigative  
pathology. 
n University of California, San Diego Cancer 
Center 
n University of Glasgow 
n The University of Iowa 
n University of Kansas Medical Center 
n University of Massachusetts, Amherst- 
College of Natural Sciences and  
Mathematics 
C.R. Bard
For almost 100 years, C.R. Bard, Inc., a 
leading multinational developer, manu- 
facturer, and marketer of innovative, life-
enhancing medical technologies in the 
fields	of	vascular	urology,	oncology,	and	
surgical specialty products, has committed 
its resources to creating innovative products 
and services that meet the needs of health 
care providers and patients. 
Bard pioneered the development of single-
patient-use medical products for hospital 
procedures; today Bard is dedicated to 
pursuing technological innovations that 
offer	superior	clinical	benefits	while	helping	
to reduce overall costs.
Bard’s outreach programs in New Jersey 
include:
n The company is currently paying off a 
$250,000 pledge to the Meridian Health 
Foundation ($50,000 per year) for the 
Bard Nursing Education Foundation  
Endowment Fund.
n The company is currently paying off a 
$60,000 pledge to the “Give a Boy a 
Year” Financial Aid Program ($15,000 per 
year) at the Delbarton School.
n The company is currently paying off a 
$50,000 pledge to the New Jersey SEEDS 
capital campaign ($10,000 per year).
n The company is currently paying off a 
$25,000 pledge to the “Building Our Chil-
dren’s Tomorrow” Campaign ($5,000 per 
year).
n Annual contribution of $25,000 to the  
Tri-County Scholarship Fund.
n Annual contribution of $17,500 to the  
Independent College Fund of New Jersey 
in support of the C.R. Bard Foundation 
Nursing Scholarship Program.
n Annual contribution of $15,000 to the 
Summit Speech School early intervention 
and preschool program.
n Annual contribution of $6,000 to The Col-
lege of New Jersey in support of the C.R. 
Bard Foundation Nursing Scholarship Pro-
gram.
n Annual contribution of $5,000 to Bloom-
field College in support of the C.R. Bard 
Foundation Nursing Scholarship Program.
n Annual contribution of $5,000 to Fairleigh 
Dickenson University Charter Day Scholar-
ship Fund.
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Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. is the U.S. subsidiary of 
Tokyo-based Daiichi Sankyo Co., Ltd., a 
leader in global pharmaceutical innovation 
and the second-largest pharmaceutical 
company in Japan. With a century of 
discovery by its Japanese parents as a 
guide, Daiichi Sankyo joins together a solid 
combination of rigorous invention and 
operational excellence that works to deliver 
therapies that put lives into balance, and 
add to the balance of life.
Headquartered in Parsippany, NJ, 
the company’s strengths include an 
expanded product portfolio, global clinical 
research capabilities, and a promising 
pipeline. Balancing a spirit of invention 
with	a	commitment	to	scientific	rigor,	
Daiichi Sankyo is a primary source of new 
therapeutic agents, including important 
medicines for cardiovascular disease.
Medical Affairs Fellowships
Daiichi Sankyo offers two unique and 
rewarding one-year fellowships in Medical 
Affairs that immerse the fellows in the real 
world of a pharmaceutical company. A 
unique opportunity for recent graduates 
to gain valuable industry experience, the 
program is geared toward transforming the 
fellows from students into pharmaceutical 
professionals.
A team approach is emphasized and 
the fellows are integrated into cross-
functional groups involving the Marketing, 
Sales Training, New Product Planning, and 
Regulatory departments. The program also 
offers a strong field-based component 
where fellows work closely with medical 
liaisons and have the opportunity to 
interact with key opinion leaders in the 
cardiovascular and metabolic therapeutic 
areas. All of these experiences are tailored 
to meet the individual needs of the fellows 
and to help them become more confident 
in their personal career development.
Management Development Program 
As a company facing substantial near term 
growth, Daiichi Sankyo has established 
a Management Development Program 
aimed at recruiting M.B.A. students from 
universities across the United States. The 
current program includes nine universities, 
all with top M.B.A. programs in Marketing 
and Pharmaceutical/Health Care 
Management. Rutgers University has 
become a primary source for the company 
in its M.B.A. recruiting initiative.  
 
Participants of the Management 
Development Program begin their rotation 
as a Sales Representative for 12 to 18 
months. Upon successful completion of 
this rotation, participants can transfer 
to a corporate position in areas such as 
Marketing Research, Market Planning, New 
Product Planning, Brand Management, 
Managed Care, or Sales Operations. The 
rotational assignments provide a solid 
foundation of experience for future growth 
opportunities within Daiichi Sankyo.    
 
Daiichi Sankyo maintains an ongoing 
relationship with the students and 
faculty from the each of the targeted 
M.B.A. schools. As part of its recruiting 
initiative, first- and second-year M.B.A. 
students are invited to Daiichi Sankyo to 
meet and speak with members of the senior 
management team. The students are given 
a high-level overview of the company, 
the Management Development Program, 
and key business units including Marketing, 
Market Research, Sales Training, Sales 
Operations, Managed Care, and Supply 
Chain.  
Daiichi Sankyo also participates in on-
campus recruiting for its Management 
Development Program at each designated 
school. Presentations are delivered 
by members of the company’s senior 
management team, and visits include on-
campus interviews of second-year M.B.A. 
students.   
Internship Program
Daiichi Sankyo works with a number of 
New Jersey colleges, such as Rutgers 
University, Stevens Institute of Technology, 
St. Elizabeth’s College, New Jersey Institute 
of Technology, and Montclair State 
University, and associations such as Inroads 
of New Jersey, to identify and employ 
students working toward degrees in areas 
such as Finance, Human Resources, and 
Information Technology. The company’s 
internship program continues to be a 
successful means of providing hands-on 
business experience to students, as well 
as creating a solid candidate pool for 
potential employment post graduation. 
Johnson & Johnson
J&J is the world’s most comprehensive and 
broadly based manufacturer of health care 
products, as well as a provider of related 
services, for the consumer, pharmaceutical, 
and professional markets.  
J&J scientists currently are engaged in 
research to bring new hope to Alzheimer’s 
patients, to develop treatments for 
ulcerative	colitis,	and	to	find	better	ways 
to detect and treat cancer and diabetes. 
Johnson & Johnson’s prescription 
pharmaceuticals include products for 
family planning, psychiatry, mental illness 
and diseases of the nervous system, 
gastroenterology, oncology, 
immunotherapy and cardiovascular 
disease, as well as biotechnology-derived 
products. The company has introduced 
prescription antifungals, anthelmintics, 
antihistamines, antiparasites, and 
antiallergy products.  
Headquartered in New Brunswick, NJ 
since its founding in 1886, Johnson & 
Johnson is recognized for its support of the 
communities in which the company has 
operations. Its extensive social responsibility 
program is an outgrowth of the company’s 
renowned credo, which outlines its 
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responsibilities to consumers, employees, 
the community, and shareholders. 
Johnson & Johnson is engaged in a number 
of workforce development and education 
incentives, including:
n Bridge to Employment is a national 
school-to-career grant program active 
in eight communities around the United 
States and Puerto Rico. In New Jersey, the 
company has current sites in Bound Brook 
and New Brunswick. For 2006-2007, J&J is 
developing a project in Trenton with Jans-
sen Pharmaceutica. Total grant dollars for 
2006-2007 New Jersey sites total $70,000.
n Liberty Science Center (LSC) funding is di-
rected to the LSC’s “Cardiac Classroom,” 
as well as a new effort to offer profes-
sional development for science teachers. 
Cardiac Classroom exposed K-12 students 
to a live, interactive, surgical procedure 
with special emphasis on health care ca-
reers. The professional development initia-
tive will be an innovative experience for 
teachers using the museum as a learning 
and teaching laboratory. Total grant dol-
lars for 2006-2007 for these initiatives total 
$300,000.
n J&J works with Rutgers University to fund 
two major initiatives targeted to K-12 stu-
dents: the Saturday Science Academy 
and the Douglass Science Institute. These 
projects total approximately $60,000.
n Independent College Fund of New  
Jersey. J&J’s 2005 grant has enabled 
six member institutions to develop and 
implement projects. 
n Bloomfield College has implemented a 
program titled “Improving Academic 
Success Through Technological Support.” 
This program assists incoming students in 
need of remedial math and/or English 
tutoring, helps juniors and seniors with 
coaching regarding job placement or 
graduate school, and brings together the 
institution’s student support services in a 
Center for Academic Development. 
n Centenary College has implemented a 
First-Year Experience Program that has 
involved 265 freshmen in a special aca-
demic track that is complemented by 
service learning. These students have had 
extensive community service participa-
tion over the past year working in the 
area of equine rescue, a local kindergar-
ten, and a retirement community and at 
The Matheny School. 
n Drew University established a Retention 
Task Force that linked admissions, finan-
cial aid, academic affairs, student affairs, 
the graduate school, the registrar, institu-
tional research, and the alumni offices. 
The Task Force has developed a Reten-
tion Marketing Program that is being 
rolled out institution-wide. 
n Georgian Court University has joined a 
highly selective initiative of the Policy 
Center for the First Year of College. This 
network of 300 institutions only offers 
membership to less than 20 new institu-
tions per year. The Center’s Foundations 
of Excellence program is a comprehen-
sive, guided self-study process for evalu-
ating and enhancing an institution’s abil-
ity to realize its goals for student learning, 
success, and persistence to degree. It is 
based on a set of Foundation Dimensions 
that guide measurement of institutional 
efforts and provide an aspirational model 
for the entirety of the college experience 
from beginning contact with prospective 
students through admissions, orientation, 
the first-year curriculum, and the transition 
to second year. 
n The approach at Saint Peter’s College 
is parent-centered in that so many of its 
incoming students are first generation 
college students and there is a need to 
orient the parents about the experience 
their sons and daughters will have as col-
lege students. This way, the parents can 
reinforce the college’s retention goals. 
This project has included an expanded 
summer orientation that involves parents. 
A Parents’ Webpage has been estab-
lished, a communications campaign will 
be conducted, and Parents’ Weekend 
in mid-October is especially themed to 
complement this initiative. 
n Seton Hall University is taking an interven-
tional approach by extending admission 
to a small group of at-risk students and 
involving them in a summer semester 
preparatory to the arrival of the freshman 
class in September. Some 90 students 
who scored below 1,000 on the SATs but 
who have the potential for success were 
identified and invited to participate this 
summer. Currently 21 have accepted the 
offer and are enrolled. The program ran 
from July 5 to August 8 with the students 
taking seven credits (two courses) and 
participating in mandatory study halls. 
n Physician Scientist Training Program at 
Temple University. This program was es-
tablished to identify exceptionally gifted 
minority students beginning as early as 
grade 7 and place them in a long-term 
comprehensive training curriculum that 
continues through medical/graduate 
school. Each year, approximately 15-20 
students are selected from a national 
pool of candidates. Participants are ex-
posed to various research environments 
(academia, government laboratories, 
and industry). The program consists of 
a 10-week summer institute at the junior 
high level and an apprenticeship in a re-
search laboratory and hospital setting in 
grade 9. Beginning in grade 10, trainees 
intern with a biomedical investigator and 
are encouraged to conduct their own 
research. Johnson & Johnson has sup-
ported this program at the $50,000 level 
for a number of years
n Business Coalition for Education Excel-
lence (BCEE). BCEE was founded to 
advocate for high standards and assess-
ments in New Jersey public education. 
J&J supports the efforts to create rigorous 
core content standard and workplace 
readiness skills. Support for this program is 
$25,000.
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n In addition, J&J supports the following ed-
ucation organizations on an annual basis: 
InroadsNJ ($10,000), Junior Achievement 
New Jersey ($5,000), Public Education 
Institute ($10,000), and Teach for America 
New Jersey ($15,000).
Merck & Co. Inc.
Merck & Co. Inc. is a global research-
driven pharmaceutical products company 
headquartered in Whitehouse Station, 
NJ. Merck employs nearly 64,000 people 
worldwide, conducts research in 10 major 
research	centers	(with	an	11th	under	
construction),	and	operates	31	production	
facilities and 17 distribution centers in 25 
countries.	In	2003,	Merck’s	global	sales	were	
$22.5 billion.
Since its founding in 1891, Merck 
researchers have pioneered innovations 
for treating serious diseases, a tradition that 
produced such major medical advances 
as cortisone for rheumatoid arthritis, 
streptomycin for tuberculosis, statins for 
cholesterol management, and Crixivan for 
HIV/AIDS,	to	name	a	few.
Today, many of Merck’s major products are 
market leaders. Current products include 
Singulair	(asthma	and	seasonal	allergies),	
Fosamax	(osteoporosis),	Zocor	(cholesterol),	
Cozaar/Hyzaar	(hypertension),	and	Zetia	
(cholesterol),	which	was	developed	
through a partnership with Schering-Plough 
Corporation.
Merck’s longstanding record of 
achievement continues as the company 
works to develop breakthrough medicines 
and vaccines. Today, Merck scientists are 
focusing on novel treatments in critical 
areas such as diabetes, obesity, Alzheimer’s 
disease, respiratory disease, coronary heart 
disease, rheumatoid arthritis, cancer, and 
vaccines.
Recognizing that serving the public interest 
also serves our business interests, Merck 
is a leader in global health policy issues 
worldwide. In the United States, Merck 
provided its medicines for free to more 
than 600,000 Americans in need last year 
through its Patient Assistance Program. In 
the developing world and in those countries 
hardest hit by the epidemic, Merck offers 
its	HIV/AIDS	medicines	at	prices	at	which	it	
does	not	profit.	And,	through	a	partnership	
with the government of Botswana and 
the Bill and Melinda Gates Foundation, 
Merck has helped build a large-scale, 
comprehensive	program	focused	on	HIV/
AIDS prevention, treatment, care, and 
support. As part of the program, the Merck 
Company Foundation and the Bill and 
Melinda Gates Foundation each provided 
$50 million to the partnership. 
With a focus on discovering and develop- 
ing novel medicines and vaccines, as well 
as innovative programs and policies to 
ensure that people throughout the world 
have access to them, Merck contributes 
to improving the health of people in all 
nations. 
The following summarizes Merck & Co.’s 
higher education partnerships in  
New Jersey:
Career Opportunities
In informing students in the state’s colleges 
about career opportunities, Merck 
maintains an active relationship with 
several New Jersey universities, including 
Rutgers, NJIT, Princeton, Rider, and Stevens 
Institute of Technology. At these schools, 
there are regular informational meetings 
and recruiting visits for needs that match 
appropriate academic programs offered. 
In addition, Merck has a highly active 
internship program that includes a selective 
Engineering and Technology (E&T) Fellow 
program, as well as other summer intern 
opportunities for undergraduates, graduate 
students, and M.B.A.s. The company has 
found that these intern programs are highly 
beneficial in informing students about 
Merck as well as aiding identification of 
talent for the future. Merck’s internship 
program and new college graduate job 
opportunities are described and posted on 
the merck.com/careers website. 
Internship Programs
As noted above, Merck has active 
internship programs for undergraduate and 
graduate students. Its E&T Fellow program 
provides the opportunity for the selected 
student to have a paid intern assignment as 
well as a scholarship.   
In addition, the Merck/AAAS 
Undergraduate Science Research Program 
(USRP) is a national competitive award 
program, focusing on primarily under- 
graduate institutions, which provides 
$60,000 in grant funding over a three-year 
period to 15 successful applicants each 
year. The funds are used to provide 
research stipends to undergraduate 
students working with faculty mentors on 
interdisciplinary research projects and to 
support related programs that enhance 
the research and educational experience. 
Three New Jersey universities are current 
Merck/AAAS USRP grant recipients: Drew 
University, Fairleigh Dickinson University, and 
Rider University. For more information, visit 
www.merckaaasusrp.org.
Developing College Curriculum
In the past, Merck has provided input 
through specific faculty and departmental 
contacts regarding course content, 
structure, and alignment on both Merck 
and general industry needs for graduating 
professionals. Specifically, Merck is actively 
involved with the Rutgers Pharmaceutical 
M.B.A. program as a financial supporter 
of their Industry Scholars program, and is 
represented on their Board of Advisers.  
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In addition, the Merck Institute for Science 
Education was awarded a grant from 
the National Science Foundation to work 
with Kean University’s mathematics and 
science departments and the School 
of Education. Through the grant, Kean 
academic faculty will be equipped to 
deliver inquiry-centered science and 
mathematics courses for undergraduates 
using effective strategies to increase 
student interest and learning, resulting 
in a higher number of educators who 
understand science and mathematics 
content and improving their instructional 
practice.
Continuing Education
Merck encourages its employees to 
continue their education via appropriate 
pathways. These include part-time 
education at local universities (e.g., 
Rutgers) that may be part of an overall 
degree-granting program. The breadth 
of available programs has historically met 
these needs without specific “designed-
for-Merck” programs. However, Merck has 
partnered with Stevens Institute of 
Technology to offer employees a Master 
of Science in Information Systems (M.S.I.S.) 
at two remote locations: Raritan Valley 
Community College and a hotel near 
Merck’s Rahway facility.
The New Jersey college partners involved 
in partnerships and the specific degrees/
programs that are involved are: 
n Rider University: Undergraduate Finance      
 and Accounting
n Rutgers: Engineering (especially Chem-
ical, Mechanical)/Science (Chemistry, 
Pharmacy) at all degree levels, Human 
Resources Masters Program (School of 
Management and Labor Relations), Busi-
ness School including the Pharmaceutical 
M.B.A. Program 
n NJIT:  Engineering at all degree levels
n Princeton: Engineering/Science/Informa-
tion Technology at all degree levels 
n Stevens: Engineering/Science/Information 
Technology at all degree levels 
Novartis Pharmaceuticals  
Corporation
Novartis Pharmaceuticals Corporation is 
the	U.S.	affiliate	of	Swiss-based	Novartis	
AG, a world leader in health care, with 
core businesses in pharmaceuticals, 
consumer health, generics, eye care, and 
animal health. Operating in more than 
140 countries, Novartis Group employs 
approximately 81,000 people around the 
world. 
Since its creation in 1996 from the merger 
of Swiss giants Ciba-Geigy and Sandoz, 
each bringing more than 100 years of 
experience to the union, the Novartis Group 
is securing a leadership position in the highly 
competitive health care industry. 
Novartis Pharmaceuticals Corporation, 
headquartered on a 200-acre campus in 
East Hanover, NJ, employs 11,200 people 
at three sites in East Hanover and Florham 
Park, NJ, and Suffern, NY and in four sales 
regions throughout the country.
Novartis Pharmaceuticals Corporation 
(NPC),	one	of	the	Novartis	Group	
Companies, researches, develops, 
manufactures, and markets leading 
innovative prescription drugs used to treat 
a broad range of disease areas including: 
cardiovascular, endocrine, and respiratory 
diseases; dermatology; gastroenterology; 
infectious diseases; neuroscience; 
oncology/hematology; rheumatism/bone 
and hormone therapy; ophthalmology; and 
transplantation.
County College of Morris Foundation
Novartis awarded $10,000 to County 
College of Morris Foundation in support 
of four scholarships for County College of 
Morris students. 
Drew University
Novartis Awards in Science Program. 
Novartis awarded the college $8,000 
for eight scholarships to Drew University 
students.
Fairleigh Dickinson University
Novartis awarded Fairleigh Dickinson 
University $15,000 in support of the Science 
Scholarship Program at the university’s 
Maxwell Becton College and Florham Park 
campuses.
New Jersey City University Foundation Inc.
Novartis awarded the university $10,000 
in support of its Proyecto Science 
academic enrichment program for Latino 
students interested in pursuing careers in 
mathematics, science, engineering, and 
technology.
Rutgers PharmD Fellowship Program
A two year Post-Doctoral Pharmaceutical 
Industry Fellowship designed to identify 
practice opportunities for pharmacists 
within Novartis through assignments that will 
build depth of experience and enhance 
the potential for accelerated career 
development. In 2006, Novartis contributed 
a total of $857,600 to Rutgers in support of 
the program.
Rutgers Graduate School of Business
Novartis is a funding supporter of the 
Rutgers Pharmaceutical Management 
M.B.A. Program.
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Novo Nordisk
Novo Nordisk is a health care company 
with an 80-year history of innovation 
and achievement in diabetes care. In 
addition to diabetes care, Novo Nordisk 
has a leading position within areas such 
as hemostasis management, growth 
hormone therapy, and hormone therapy 
for women. Novo Nordisk’s business is driven 
by the Triple Bottom Line: a commitment 
to economic success, environmental 
soundness, and social responsibility 
to employees and customers. With 
headquarters in Denmark, Novo Nordisk 
employs	more	than	23,600	employees	in	79	
countries, and markets its products in 179 
countries. Novo Nordisk’s B shares are listed 
on the stock exchanges in Copenhagen 
and London. Its ADRs are listed on the 
New York Stock Exchange under the 
symbol	‘NVO’.	For	global	information,	
visit novonordisk.com; for United States 
information, visit novonordisk-us.com. 
Novo Nordisk has a number of workforce 
and education programs, including:
Novo Nordisk Mentoring Program 
Each month, Novo Nordisk welcomes 10 
new Trenton High School students to its 
Plainsboro offices as part of a mentoring 
program the company offers attendees 
of the school’s Law and Justice Academy. 
Participants learn about various legal 
and other business topics. For the past 
four years, Novo Nordisk has provided 
computers for participants to use 
throughout their high school careers.
Management Associate Program (MAP)
This program offers both summer and 
two-year employment opportunities for 
graduate students at targeted graduate 
school across the country.
INROADS Intern Program
This program is a partnership between the 
INROADS organization and Novo Nordisk 
to place diverse, undergraduate college 
students already accepted by INROADS 
into summer internships at Novo Nordisk.
PharmD Residency Program
This program provides an opportunity for 
pharmacy professionals to gain experience 
in drug information, as well as other 
functional areas within the pharmaceutical 
industry.
Informal Internships
Although there is no formal summer 
internship program for high school or 
college students (not already included in 
INROADS) at Novo Nordisk, there are often 
individual opportunities within business units. 
Should there be a need within a team or 
department, positions are often posted 
directly with local colleges and universities.
Organon USA
Organon Inc. of West Orange, NJ is the 
U.S.	affiliate	of	N.V.	Organon,	a	renowned	
international ethical pharmaceutical 
company. 
Organon maintains a strong commitment 
to health care, conducting research in the 
areas of psychiatry, contraception, fertility, 
anesthesiology, thrombosis, immunology, 
osteoporosis prevention, and treatment of 
postmenopausal symptoms.
Organon is one of the business units of 
AKZO Nobel. Headquartered in the 
Netherlands, AKZO Nobel is a market-
driven and technology based company, 
serving customers throughout the world 
with healthcare products, coatings, and 
chemicals. The company employs 68,000 
people and has activities in more than 75 
countries.
Based	in	Oss,	The	Netherlands,	N.V.	
Organon began as the unlikely 
collaboration of three men: Dr. Saal van 
Zwanenberg, owner of a meat processing 
firm;	Dr.	Ernst	Laqueur,	a	leading	endo- 
crinologist and professor of pharmacology 
at the University of Amsterdam; and 
Dr. Jacques van Oss, a mathematician 
from Amsterdam. Their theory that 
hormones present in animal organs 
could be extracted for the production of 
standardized human pharmaceuticals 
was	proved	to	be	true	in	1923	with	the	
development	of	the	first	rapidly	acting	
insulin for diabetes control and discovery 
of estrogen that followed three years later. 
This marked a beginning of what became 
the most acclaimed Organon’s endeavor: 
isolation and then mass-production of 
reproductive hormones.
Today, over three-quarters of a century 
later, Organon has compiled a long and 
impressive	list	of	firsts	in	pharmaceutical	
discovery and development, innovative, 
new generation products. Market-driven 
and research-based, Organon has always 
remained adherent to its main mission: 
contributing and making the difference 
where health and people matter.
Strong reliance on its expertise in research 
and development and unprecedented 
commitment to women’s health care 
allowed	Organon	to	contribute	significantly	
to three areas of vital importance — 
contraception, fertility, and osteoporosis 
prevention — and placed the company in 
range	of	world	leaders	in	this	field.
Organon’s scientists and research assistants 
worldwide have also added strongly 
to groundbreaking research programs 
and treatment of central nervous system 
disorders, especially depression and 
psychosis	as	well	as	diversified	and	highly	
specialized anesthesia products.
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Proud of the past and in control of the 
present, Organon reaches to the future 
showing	promising	research	in	the	fields	of	
cardiovascular diseases and immunology. 
Compounds for the treatment of athero-
thrombosis and rheumatoid arthritis entered 
advanced stages of development to 
further address the growing patients’ needs 
and extend Organon’s product portfolio.
Specifically	in	the	United	States,	Organon	
not only develops, manufactures, and 
markets pharmaceuticals, but also provides 
educational resources and programs 
to support physicians and their patients. 
Products currently marketed in the 
United States include oral contraceptive 
MIRCETTE®	(desogestrel/ethinyl	estradiol	
and	ethinyl	estradiol),	injectable	fertility	
treatment	FOLLISTIM®	(follitropin	beta	
for	injection),	an	innovative	FOLLISTIM®/
ANTAGON®	(follitropin	beta	for	injection	
and	ganirelix	acetate)	kit	with	the	
innovative GnRH-antagonist, and a 
PREGNYL®	(chorionic	gonadotropin	for	
injection,	USP).	In	addition,	Organon	
markets	REMERON®	SolTab™	(mirtazapine)	
antidepressant orally disintegrating tablets, 
muscle	relaxants	ZEMURON™	(rocoronium	
bromide)	and	RAPLON™	(rapacuronium	
bromide),	and	anticoagulant	ORGARAN®	
(danaparoid	sodium)	injection.
Organon’s commitment to health care 
research and development continues with 
joined efforts of nearly 2000 employees 
in	the	United	States	(a	number	of	whom	
quadrupled	in	the	past	10	years)	and	
accounts for the dynamic growth in all 
Organon’s	therapeutic	fields.
Partnership with Rutgers Graduate 
Business School Pharmaceutical M.B.A. 
Program
Organon is one of seven corporate sponsors 
of this program. As a corporate sponsor, 
the company hosts a yearly seminar that 
provides the management students with 
relevant industry topics that will prepare 
them for their future careers. Such topics 
include: Role of FDA and the relationship 
with the Pharmaceutical Industry. Direct to 
Consumer Advertising.
College Recruiting Venues
Organon is proud to be an active 
participant at Rutgers University (both 
undergraduate and graduate), Seton Hall 
University, St. Peter’s College, and Fairleigh 
Dickinson University. 
PharmFest 2006
Organon participated in PharmFest in 
2006 at Montclair State University. This 
program allowed high school and college 
students an opportunity to explore career 
opportunities within the pharmaceutical 
industry.  
Internships
Organon provides internship programs for 
primarily bachelor’s and graduate degree 
students. These internships are in various 
areas of the business including Market 
Research, Brand Management, Corporate 
Finance, Field Sales, Human Resources, and 
Medical Affairs. These programs are held 
during the summer as well as during the 
regular school year. Organon also includes 
graduating high school seniors in these 
internships as well.
Organon has partnered with INROADS- 
Northern New Jersey since 1999. In doing 
so, the company has consistently offered 
internship opportunities for INROADS 
students, and also assists in facilitating such 
programs as resume critique and mock 
interviews. In 2006, Organon USA Inc. hosted 
an INROADS talent pool event on-site in its 
corporate headquarters in Roseland, NJ.
Curriculum Development
Organon has participated in such design/
modification of curriculum for both St. 
Peter’s College in Jersey City and Rutgers 
University (Pharmaceutical M.B.A. Program) 
in Newark, NJ. 
Continuing Education
Organon is in the process of discussing with 
St. Peter’s College in Jersey City, NJ the 
possibility to host an on-site program. At this 
time, no formal program is set, however this 
is under consideration for 2007.
Pfizer
Pfizer	is	a	research-based,	global	
pharmaceutical	company.	Pfizer	has	two	
business segments: health care and animal 
health.	The	Pfizer	pharmaceutical	product	
portfolio is one of the broadest and deepest 
in the industry, covering cardiovascular 
disease, infectious disease, diseases of the 
central nervous system, metabolic disorders, 
cancer,	inflammatory	diseases,	women’s	
health, and ophthalmology. Although 
Pfizer’s	headquarters	is	in	New	York	City,	it	
maintains several operational sites in New 
Jersey.
Pfizer and its employees give approximately 
$7 million in charitable contributions 
and product donations in the state of 
New Jersey every year. In addition, Pfizer 
conducts a number of educational 
initiatives at all educational levels in the 
state. Specific support to higher education 
includes: 
n Morristown High School Career Academy 
in Science
n Fairleigh Dickinson University Summer  
Science Program
n Drew University Summer Scholars Program 
n Rutgers University Bio Statistical program
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n Independent College Fund — Pfizer  
Undergraduate Research Educational 
Grant (PURE)
n County College of Morris County Founda-
tion Scholarship
n Centenary College
n William Paterson University Distinguished 
Lecture Series
n Tri-County Scholarship Fund
n St. Elizabeth College
n Newark Academy Scholarship
n INROADS Internship Program
n Liberty Science Center — Traveling  
Science Program for schools
Roche
Hoffmann-La Roche Inc. is the U.S. 
prescription drug unit of the global health 
care company, the Roche Group, founded 
in 1896 in Basel Switzerland. Known simply as 
Roche, the company is a leading innovator 
of medicines and services that enhance 
people’s health, well-being, and quality 
of life. Roche global businesses include 
Pharmaceuticals and Diagnostics, and 
employs more than 74,000 people and sells 
its products in over 150 countries.  
In the U.S., Roche markets medicines for 
cancer,	hepatitis	C,	HIV/AIDS,	influenza,	
osteoporosis, and transplantation. In most 
of the product markets in which Roche 
competes, the company’s drugs rank 
among the top in their class.
Roche established U.S. operations in New 
York City in 1905 and moved them to 
Nutley, NJ in 1929. Located on a 127-acre, 
university-like campus, the Nutley site is 
now the headquarters of Roche’s U.S. 
Pharmaceuticals business and employs 
some	3,000	people	who	work	in	the	
discovery, development, manufacturing, 
and marketing of prescription medicines. 
Areas of key research conducted in Nutley 
include the search for treatments for 
metabolic,	inflammation	and	autoimmune	
diseases, and cancer. In addition to 
the people on the Nutley campus, 
the company has an award-winning, 
nationwide sales force.
An employer of choice, Roche has been 
named one of the top 20 Pharmaceutical 
and	Biotech	employers	(Science 
magazine),	ranked	as	the	no.	3	best	
company	to	work	for	in	New	Jersey	(NJBIZ 
magazine),	the	no.	1	company	to	sell	for	
(Selling Power), and one of AARP’s top 
companies for older workers. In 2005, Roche 
was named one of Fortune magazine’s best 
companies to work for in America.
Over the past several years, Roche has 
built partnerships with several educational 
institutions in New Jersey:
n Fairleigh Dickinson: Courses are held on 
the Nutley campus to support continuing 
professional development to company 
employees.
n Independent College Fund of New Jer-
sey: Science and math scholarship (un-
dergraduate).
n Montclair State University Foundation: 
Bilingual science project (undergraduate 
majoring in science education).
n New Jersey City University: Summer  
Science program (undergraduate).
n New Jersey Institute of Technology:  
Research Interns (undergraduate).
n William Paterson University: Bio-Ethics 
training for science teachers  
(undergraduate).
n Ramapo College Foundation: Science 
and math scholarship (undergraduate).
n Rutgers University: Founding sponsor of 
the Pharmaceutical Management  
Scholars Program (M.B.A.) within Rutgers 
Business School. Participated in assess-
ment of Scholars program candidates 
and evaluation of the program  
curriculum. 
n Rutgers University: Active sponsor and 
participant in the Rutgers Pharmaceutical 
Industry Fellowship through the Ernest  
Mario School of Pharmacy.
n Rutgers University Foundation: Support for 
special science teams (undergraduate).
In addition, Roche sponsors a compre- 
hensive Summer Intern Program for 
undergraduate and graduate students. In 
2006, Roche hosted summer interns from 
several New Jersey colleges and universities 
including Rutgers University, Montclair State 
University, Fairleigh Dickinson University, New 
Jersey City University, and The College of 
New Jersey.
sanofi-aventis
sanofi-aventis	is	one	of	the	world’s	leading	
pharmaceutical companies. Backed by a 
world-class	R&D	organization,	sanofi-aventis	
is developing leading positions in seven 
major therapeutic areas: cardiovascular, 
thrombosis, oncology, metabolic diseases, 
central nervous system, internal medicine, 
and vaccines. 
sanofi-aventis	is	dedicated	to	improving	
public health by meeting the needs of its 
patients. It has a world-class R&D program 
driven by a commitment to address the 
world’s expanding needs to prevent, treat, 
or cure diseases known today and those 
that will be faced tomorrow.
With over 4,000 employees in New Jersey, 
sanofi-aventis focuses many of its efforts 
on higher education to support the 
communities in which the company’s 
employees live and work, including:
n A fellowship program with Rutgers Uni-
versity in an innovative program to pro-
vide training within the pharmaceutical 
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industry tailored to the needs of PharmD 
graduates. The fellowship experience at 
sanofi-aventis provides a solid foundation 
for future career success.
n An M.B.A. Minds Matter program with 
Rutgers University and several other U.S. 
universities to attract and retain excep-
tional talent into the field of pharmaceuti-
cal operations. This program also helps 
identify and cultivate future leaders with 
superior business acumen and leadership 
skills and supplement talent management 
strategies used in developing current  
employees.
n Opportunities with science and medical 
affairs for undergraduates from Rider Uni-
versity, the College of New Jersey,  
Rutgers, and Seton Hall University to  
attract candidates with biology and 
chemistry backgrounds for careers in 
drug discovery.
Schering-Plough Corporation
Schering-Plough Corporation is a global 
science-based health care company 
with leading prescription, consumer, and 
animal health products. Through internal 
research and collaborations with partners, 
the company discovers, develops, 
manufactures, and markets advanced 
drug therapies to meet important medical 
needs. Schering-Plough’s vision is to earn 
the trust of the physicians, patients, and 
other customers served by approximately 
33,500	people	around	the	world.	The	
company’s products reach patients and 
caregivers in more than 120 countries. In 
2006, net sales totaled $10.6 billion.
Schering-Plough is continuing a 
fundamental transformation under a six- to 
eight-year action agenda that began in 
2003	upon	the	arrival	of	CEO	Fred	Hassan.	
The company invested approximately 
$2.2 billion in research and development 
in 2006. Current areas of therapeutic 
focus are various cancers, infectious 
diseases, acute and chronic respiratory 
conditions,	inflammatory	diseases,	
cardiovascular and metabolic diseases, 
and neurodegenerative diseases.
Drew University
An annual grant supports the “Schering-
Plough Summer Research Scholars,” an 
undergraduate research initiative at the 
university. The program funds participation 
by two science students and their faculty 
mentors during the summer months.
Kean University
“Students Partnering with Faculty Summer 
Research Program” allows students 
majoring in mathematics, computer 
science, biological sciences, chemistry, or 
physics to work with faculty members to 
initiate original research projects during 
a six-week summer session. Research 
continues in the fall, with work culminating 
in presentations at regional and national 
conferences, in journal publications, and 
on the Internet. Schering-Plough is the sole 
funder of the program.
Also at Kean, Schering-Plough provided 
support necessary to inaugurate the 
university’s master’s degree program in 
biotechnology. Schering-Plough remains 
involved, as company researchers serve as 
adjunct faculty and matriculating students 
receive practical experience in company 
laboratories. A number of Schering-Plough 
colleagues have completed the degree 
program.
New Jersey City University
The “Schering-Plough Corporate Scholars 
Program” funds tuition for the final two 
years of college for chemistry majors who 
are members of minority groups. Two 
scholars are selected annually. The students 
participate in paid summer internships, 
working side-by-side with Schering-Plough 
researchers.
New Jersey Institute of Technology
Schering-Plough supports NJIT’s annual 
Chemical Engineering Scholarship. The 
company provides significant resources 
to fund scholarships for students enrolled 
in NJIT’s Albert Dorman Honors College. 
Schering-Plough is a major funder of the 
institute’s master’s degree program in 
Pharmaceutical Engineering. This is one of 
very few such programs in the country and 
helps meet the pharmaceutical industry’s 
critical need for skilled professionals in the 
areas of pharmaceutical facilities design, 
drug manufacturing, and pharmaceutical 
product development. Schering-Plough 
colleagues are significantly involved in the 
program as guest lecturers and mentors.  
Rider University
The “Schering-Plough Science Scholarship” 
benefits economically disadvantaged Rider 
students majoring in one of the sciences.
Rutgers University
A Schering-Plough endowment funds 
scholarships for students of the Ernest Mario 
College of Pharmacy. The John J. Heldrich 
Center for Workforce Development is 
the recipient of significant funding from 
Schering-Plough in support of its mission to 
enrich career opportunities for New Jersey 
residents.
Schering-Plough Foundation Scholars 
Program
Six New Jersey colleges and universities 
receive annual funding for scholarships to 
provide financial assistance to students who 
demonstrate financial need.
Seton Hall University
Schering-Plough is a major funder of the 
chemistry teaching laboratory at Seton 
Hall’s new Science and Technology Center.
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The College of New Jersey
A grant to the college supports Educational 
Opportunity Fund scholarships for 10 
students who have demonstrated financial 
need. The recipients, who are students 
studying science or business administration, 
participate in a paid summer internship 
opportunity at Schering-Plough.
Union County College
A Schering-Plough endowment funds the 
Allied Health Scholarship Program, which 
provides tuition assistance for students 
pursuing studies in the health sciences.
University of Medicine and Dentistry of 
New Jersey
The company annually sponsors 
attendance by medical students at the 
Student National Medical Association 
Conference. Attendees participate in 
lectures, workshops, and mentorship 
exercises dedicated to retention and 
graduation of underrepresented minority 
students pursuing medical degrees. Also 
at UMDNJ, Schering-Plough funds the 
“Research Program for Undergrads in 
Neuroscience.” This summer program aims 
to introduce college students who are New 
Jersey residents to biomedical research 
opportunities in the state, particularly in the 
area of neuroscience. Virtually all program 
participants pursue studies in biomedical 
research or one of the health-related 
professions following college graduation. 
Data indicate that a growing number 
of these students choose New Jersey 
institutions for their graduate studies.
Stryker Corporation
Stryker Howmedica Osteonics is a global 
leader in the development, manufacture, 
and sale of orthopedic products and 
services. Through technology and 
innovation, it enriches the quality of life of 
patients around the world.
Orthopedic disease and trauma affect 
millions of people around the globe 
each year. They limit mobility, decrease 
productivity, and reduce the quality of 
life. Patients have come to rely on Stryker 
Howmedica Osteonics for the products 
they need to restore normal function, 
reduce pain, and return them to the 
activities of daily living.
The company’s Hip, Knee, Upper Extremity, 
Trauma, and Spinal Systems, as well as its 
Bone Cement and Bone Substitutes are 
designed to help patients lead healthier, 
more active lives. Its entire range of 
products and services makes surgery and 
recovery from an orthopedic implant 
procedure simpler, faster, and more 
effective. 
For decades, Stryker Howmedica Osteonics 
has employed innovative and experienced 
professionals to develop and introduce 
unique new products that help solve 
specific	clinical	demands	and	enhance	the	
lives of recipients. 
Stryker Howmedica Osteonics is one of 
the most successful divisions within Stryker 
Corporation, a worldwide leader in health 
care. Stryker Corporation has delivered 
more than 20 years of 25% compounded 
annual net earnings growth. Its technically 
advanced products and services are the 
direct result of an ongoing investment in 
research, development, and expansion.
Informing Students about Educational 
Opportunities in the Industry
n Advertising outreach: NextStop New Jer-
sey Magazine and NJNextStop.org adver-
torials, which reach high school students 
across the state about careers in medical 
device/pharmaceutical industry.
n College career fairs and on-campus brief-
ing sessions focused at both liberal arts 
students, as well as business and finance 
concentrations and various engineering 
disciplines: NJIT, Ramapo College,  
Rutgers, Seton Hall, Stevens Institute of 
Technology, and Bergen Community  
College.
n Job openings on college career boards: 
NJIT, Ramapo College, Rutgers, Seton 
Hall, Stevens Institute of Technology.
n Diversity career fairs. 
Stryker’s Outreach in Internships 
Programs
n Cooperative education/internships for 
Associate’s Degree: Bergen Community 
College.
n Cooperative education for Bachelor’s 
degrees in mechanical, biomedical, 
materials, operations management, and 
other engineering disciplines as well as 
marketing, finance, and accounting at 
the following institutions: Ramapo  
College, NJIT, Rutgers University, Stevens 
Institute of Technology. 
n Graduate degrees in general business, 
marketing, finance at Rutgers. 
Stryker’s Work in University Curriculum
n Partnership with Bergen Community 
College in establishment of Technology 
Education Center and establishment 
of curriculum, simulated manufacturing 
lab, and Associate’s Degree program in 
Manufacturing Technology.
n Early stage “Business Partner” with  
Ramapo College in establishment of  
Institute for Innovation and Entrepreneur-
ship, to deliver an undergraduate  
certificate program in Innovation and  
Entrepreneurship.  
n Participation at Stevens Institute of Tech-
nology with Steering Committee around 
technology and business curriculum  
approaches.
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Continuing Education Programs that Help 
Meet the Needs of the Company
n Bergen Community College, AAS degree 
in Manufacturing Technology tailored 
to the needs of medical device manu-
facturing operations including simulated 
manufacturing laboratory, course se-
quencing, and “soft skills”.
n New Jersey Institute of Technology (NJIT) 
on-site offerings, tailored to the needs 
of Stryker employees, consisted of :
l	Masters of Science in Manufacturing 
Systems Engineering
l	Masters of Business Administration 
l	Executive Masters of Business Admin-
istration (accelerated 18-month long 
program)
Wyeth
Wyeth’s vision of leading the way to 
a healthier world means discovering, 
developing, manufacturing, and marketing 
health care products that improve lives. It 
also means building charitable partnerships 
and using its resources to build a better, 
healthier way of life around the world. 
Wyeth does this by providing support 
through	financial	contributions,	product	
donations, patient assistance, volunteerism, 
and partnering with organizations that 
share similar visions and goals. Support 
is	given	to	nonprofit	organizations	that	
strive to enhance the quality of life in local 
communities through programs in health 
care, social services, education, and the 
arts.
Wyeth has a long history of providing 
support to educational institutions in New 
Jersey. Some of the programs that the 
company is supporting or has supported 
over the past few years are:
n UMDNJ School of Public Health and Rut-
gers Bloustein School of Planning and 
Public Policy: Internships for graduate and 
undergraduate students with Wyeth’s 
Global Scientific Affairs. Students have 
participated in several product develop-
ment projects in the nutritional and anal-
gesics areas.
n Seton Hall University: Wyeth Human Re-
sources has worked with the university’s 
career development program to deliver 
an annual hour-long interview skills work-
shop to graduating seniors.
n Farleigh Dickinson University and College 
of Saint Elizabeth: Internships for 2-3 un-
dergraduates throughout the calendar 
year with Wyeth Advertising.
n Rutgers University: Major contributor to 
the Rutgers University touring science 
bus, a “classroom on wheels” that trav-
els throughout all of the state’s middle 
schools.
Wyeth also offers a matching grants 
program to qualified educational 
institutions, and alumni funds, foundations, 
or associations connected with qualified 
educational institutions, equal to 50% of the 
amount contributed. In addition, Wyeth 
provides financial support to many of the 
schools’ ongoing scholarship programs 
through contributions to annual fundraisers.
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About the Report
This report is based on an online survey 
conducted in spring 2006 of the current 
and future workforce needs of compa-
nies that are members of the HealthCare 
Institute of New Jersey (HINJ). More than 
two-thirds of HINJ member companies 
(15 of 22) responded to the survey. These 
companies represent 38,000 of the 60,000 
jobs at HINJ member companies. 
The survey requested information on 
employment by functional area, oc-
cupational title, educational level, and 
degree. Data were collected on num-
ber of employees, job openings, recent 
hires, and employment projections. In 
addition, HINJ member companies were 
also asked to assess the difficulty of hir-
ing specific occupations and degrees, 
using a low-medium-high scale. Data on 
graduates of New Jersey degree pro-
grams from the New Jersey Commission 
on Higher Education were assembled to 
provide a basis of comparison for work-
force supply. Finally, structured interviews 
were conducted with human resources 
managers at HINJ member companies to 
profile the skill and educational require-
ments of high-demand occupations.
This effort was guided by the HINJ Hu-
man Resources Committee. This com-
mittee, led by co-chairs Lisa Peterson, 
Vice President, Human Resources, Stryker 
Orthopedics, and Michael Kahrer, Vice 
President, Human Resources and Business 
Services, Organon, provided essential 
guidance throughout the project. Bill 
Healey, Executive Vice President, HINJ, 
also provided valuable input and guid-
ance.
This initiative was funded by the follow-
ing participating companies: ALTANA/Ny-
comed, Bristol-Myers Squibb, GE Health-
care, Hoffmann-La Roche, Lundbeck Re-
search, Novartis, Novo Nordisk, Organon, 
Pfizer, sanofi-aventis, Schering-Plough, 
and Stryker Orthopedic.


